Goodyear Tire & Rubber Company Supports UNC Health as GammaTile Center of Excellence

Innovative Advances in Brain Tumor Treatment: UNC Health Recognized as a GammaTile Center of Excellence

In a significant development for medical technology, GT Medical Technologies designates UNC Health as a GammaTile® Center of Excellence, underscoring the institution's exceptional capabilities in patient education and clinical execution related to the GammaTile procedure. This recognition is not only a testament to UNC Health’s commitment to quality care but also highlights the growing importance of innovative treatments in the fight against brain tumors. The designation is reserved for institutions that fulfill stringent clinical criteria, which include annual case minimums and continual educational commitments for their medical staff.

The GammaTile procedure, which represents a breakthrough in radiation therapy, stands out because it allows for immediate treatment of tumor sites during surgical removal. This method enables physicians to deliver targeted radiation directly to the affected area, significantly reducing the interval between surgery and radiation therapy. By doing so, GammaTile aims to enhance treatment effectiveness against residual cancer cells while also decreasing the likelihood of tumor regrowth. Experts at UNC Health, including Dr. Michael Dance and Dr. Matthew G. Ewend, emphasize the importance of this treatment evolution, noting that it embodies a commitment to adopting evidence-based innovations that substantially improve patient outcomes.

Dr. Dominique Higgins, one of the recognized physicians at UNC Health, articulates the significance of the GammaTile designation. According to Dr. Higgins, this acknowledgment reflects the institution's dedication to pioneering advanced therapeutic options that prioritize patient care. The recognition of UNC Health as a center of excellence aligns with the growing trend of integrating cutting-edge technology into clinical practice, thereby enhancing the landscape of brain tumor treatment and improving the overall patient experience. Through its focus on evidence-based innovations, GT Medical Technologies continues to lead the charge in transforming standards of care for patients facing challenging diagnoses.

In related advancements, GT Medical Technologies remains committed to addressing the unmet needs in brain tumor care, striving to improve patient outcomes with its innovative solutions. The company’s focus on collaboration with leading medical institutions like UNC Health ensures that advancements in treatment methodologies are effectively implemented, ultimately benefiting patients. This initiative not only sets a benchmark for excellence in medical technology but also reinforces the commitment of healthcare providers to deliver high-quality, compassionate care.